Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177lu/90y-dotatoc and 213bi-dotatoc radiopeptide therapy

Збережено в:
Бібліографічні деталі
Дата:2013
Автори: F. L. Giesel, P. Flechsig, T. Kuder, L. Schwartz, S. Wulfert, C. Zechmann, F. Bruchertseifer, U. Haberkorn, C. Kratochwil
Формат: Стаття
Мова:English
Опубліковано: 2013
Назва видання:Experimental Oncology
Онлайн доступ:http://jnas.nbuv.gov.ua/article/UJRN-0000072246
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Library portal of National Academy of Sciences of Ukraine | LibNAS

Репозитарії

Library portal of National Academy of Sciences of Ukraine | LibNAS
id open-sciencenbuvgovua-80300
record_format dspace
spelling open-sciencenbuvgovua-803002024-04-16T18:15:11Z Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177lu/90y-dotatoc and 213bi-dotatoc radiopeptide therapy F. L. Giesel P. Flechsig T. Kuder L. Schwartz S. Wulfert C. Zechmann F. Bruchertseifer U. Haberkorn C. Kratochwil 1812-9269 2013 en Experimental Oncology http://jnas.nbuv.gov.ua/article/UJRN-0000072246 Article
institution Library portal of National Academy of Sciences of Ukraine | LibNAS
collection Open-Science
language English
series Experimental Oncology
spellingShingle Experimental Oncology
F. L. Giesel
P. Flechsig
T. Kuder
L. Schwartz
S. Wulfert
C. Zechmann
F. Bruchertseifer
U. Haberkorn
C. Kratochwil
Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177lu/90y-dotatoc and 213bi-dotatoc radiopeptide therapy
format Article
author F. L. Giesel
P. Flechsig
T. Kuder
L. Schwartz
S. Wulfert
C. Zechmann
F. Bruchertseifer
U. Haberkorn
C. Kratochwil
author_facet F. L. Giesel
P. Flechsig
T. Kuder
L. Schwartz
S. Wulfert
C. Zechmann
F. Bruchertseifer
U. Haberkorn
C. Kratochwil
author_sort F. L. Giesel
title Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177lu/90y-dotatoc and 213bi-dotatoc radiopeptide therapy
title_short Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177lu/90y-dotatoc and 213bi-dotatoc radiopeptide therapy
title_full Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177lu/90y-dotatoc and 213bi-dotatoc radiopeptide therapy
title_fullStr Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177lu/90y-dotatoc and 213bi-dotatoc radiopeptide therapy
title_full_unstemmed Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177lu/90y-dotatoc and 213bi-dotatoc radiopeptide therapy
title_sort contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177lu/90y-dotatoc and 213bi-dotatoc radiopeptide therapy
publishDate 2013
url http://jnas.nbuv.gov.ua/article/UJRN-0000072246
work_keys_str_mv AT flgiesel contrastenhancedultrasoundmonitoringofperfusionchangesinhepaticneuroendocrinemetastasesaftersystemicversusselectivearterial177lu90ydotatocand213bidotatocradiopeptidetherapy
AT pflechsig contrastenhancedultrasoundmonitoringofperfusionchangesinhepaticneuroendocrinemetastasesaftersystemicversusselectivearterial177lu90ydotatocand213bidotatocradiopeptidetherapy
AT tkuder contrastenhancedultrasoundmonitoringofperfusionchangesinhepaticneuroendocrinemetastasesaftersystemicversusselectivearterial177lu90ydotatocand213bidotatocradiopeptidetherapy
AT lschwartz contrastenhancedultrasoundmonitoringofperfusionchangesinhepaticneuroendocrinemetastasesaftersystemicversusselectivearterial177lu90ydotatocand213bidotatocradiopeptidetherapy
AT swulfert contrastenhancedultrasoundmonitoringofperfusionchangesinhepaticneuroendocrinemetastasesaftersystemicversusselectivearterial177lu90ydotatocand213bidotatocradiopeptidetherapy
AT czechmann contrastenhancedultrasoundmonitoringofperfusionchangesinhepaticneuroendocrinemetastasesaftersystemicversusselectivearterial177lu90ydotatocand213bidotatocradiopeptidetherapy
AT fbruchertseifer contrastenhancedultrasoundmonitoringofperfusionchangesinhepaticneuroendocrinemetastasesaftersystemicversusselectivearterial177lu90ydotatocand213bidotatocradiopeptidetherapy
AT uhaberkorn contrastenhancedultrasoundmonitoringofperfusionchangesinhepaticneuroendocrinemetastasesaftersystemicversusselectivearterial177lu90ydotatocand213bidotatocradiopeptidetherapy
AT ckratochwil contrastenhancedultrasoundmonitoringofperfusionchangesinhepaticneuroendocrinemetastasesaftersystemicversusselectivearterial177lu90ydotatocand213bidotatocradiopeptidetherapy
first_indexed 2024-04-17T05:45:25Z
last_indexed 2024-04-17T05:45:25Z
_version_ 1796885656752881664